Rab 5A Inhibitors
Rab 5A, a member of the Rab family of small GTPases, serves as a key regulator of intracellular membrane trafficking processes, particularly in the endocytic pathway. Its primary function involves the coordination of vesicle trafficking events, including endocytosis, early endosome formation, and fusion with other intracellular compartments. Rab 5A functions as a molecular switch, cycling between an active, GTP-bound state and an inactive, GDP-bound state. In its active form, Rab 5A is recruited to early endosomes, where it facilitates the fusion of endocytic vesicles and regulates the sorting and transport of cargo molecules. Through interactions with effector proteins and regulatory factors, Rab 5A orchestrates the dynamic membrane rearrangements necessary for proper endocytic trafficking.
Inhibition of Rab 5A activity can disrupt normal endocytic trafficking processes and impair cellular homeostasis. One mechanism of inhibition involves interference with the nucleotide binding and hydrolysis cycle of Rab 5A. Small molecules or proteins may target Rab 5A by preventing its activation through inhibition of guanine nucleotide exchange factors (GEFs) or by enhancing its inactivation through stimulation of GTPase-activating proteins (GAPs). Additionally, inhibition of Rab 5A function may occur through disruption of its interactions with effector proteins or other regulatory factors necessary for proper vesicle trafficking. By interfering with Rab 5A-mediated processes, inhibitors can perturb endocytic pathways, leading to aberrant vesicle trafficking, impaired cargo sorting, and alterations in cellular signaling events. Overall, inhibition of Rab 5A represents a strategy for modulating intracellular membrane trafficking and may have implications for various cellular processes and disease states.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
2-(Benzoylcarbamothioylamino)-5,5-dimethyl-4,7-dihydrothieno[2,3-c]pyran-3-carboxylic Acid | 314042-01-8 | sc-503400 | 10 mg | $300.00 | ||
A selective inhibitor of the ARF6 GTPase. By targeting ARF6, this compound indirectly impacts Rab 5A-mediated endocytosis and vesicular trafficking, affecting cellular processes reliant on Rab 5A activity. | ||||||
5-(N-Ethyl-N-isopropyl)-Amiloride | 1154-25-2 | sc-202458 | 5 mg | $104.00 | 20 | |
EIPA inhibits Na+/H+ exchangers, influencing endosomal pH. This indirect modulation alters Rab 5A-dependent endocytic trafficking by affecting vesicle fusion and protein sorting within the endosomal system. | ||||||
Vacuolin-1 | 351986-85-1 | sc-216045 | 10 mg | $265.00 | 29 | |
Vacuolin-1 induces large vacuoles by disrupting endosomal trafficking. By interfering with membrane dynamics and endosomal maturation, this compound indirectly influences Rab 5A-mediated processes, impacting vesicle trafficking and fusion. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore inhibits dynamin, essential for endocytic vesicle scission. By disrupting dynamin activity, Dynasore indirectly modulates Rab 5A-mediated endocytosis, affecting vesicle formation and subsequent intracellular trafficking processes. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits phosphoinositide 3-kinases (PI3Ks), impacting membrane trafficking. This indirect modulation alters Rab 5A-mediated endocytic pathways by affecting vesicle formation and fusion through changes in phosphoinositide composition. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A inhibits ADP-ribosylation factors (ARFs), crucial for vesicle transport. By disrupting ARF function, this compound indirectly impacts Rab 5A-mediated processes, affecting the formation and trafficking of vesicles within the endocytic pathway. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine alters endosomal pH and inhibits lysosomal enzymes. This indirect modulation influences Rab 5A-dependent endocytic processes by affecting vesicle fusion and protein sorting within the endosomal system, impacting cellular trafficking events. | ||||||
Pitstop 2 | 1419320-73-2 | sc-507418 | 10 mg | $360.00 | ||
Pitstop 2 inhibits clathrin-mediated endocytosis. By disrupting clathrin function, this compound indirectly influences Rab 5A-mediated processes, altering vesicle formation and intracellular trafficking events dependent on clathrin-coated vesicles. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
ML141 inhibits Cdc42, a GTPase involved in membrane dynamics. By modulating Cdc42 activity, this compound indirectly affects Rab 5A-mediated endocytic pathways, altering vesicle formation and intracellular trafficking events associated with Cdc42-regulated processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, impacting membrane dynamics and trafficking. This indirect modulation alters Rab 5A-mediated endocytic processes by affecting vesicle formation and fusion through changes in phosphoinositide composition, influencing PI3K-regulated pathways. | ||||||